Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study

OBJECTIVE: To evaluate the effectiveness and safety of first-generation protease inhibitors for the treatment of genotype 1 hepatitis C virus-infected patients at Brazilian reference centers. METHODS: This multicenter cross-sectional study included hepatitis C virus genotype 1 monoinfected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Callefi, Luciana Azevedo, Villela-Nogueira, Cristiane Alves, de Barros Tenore, Simone, Carnaúba-Júnior, Dimas, Coelho, Henrique Sérgio Moraes, Pinto, Paulo de Tarso A., Nabuco, Letícia Cancella, Pessoa, Mário Guimarães, Ferraz, Maria Lucia Cardoso Gomes, Ferreira, Paulo Roberto Abrão, de Lourdes Candolo Martinelli, Ana, Chachá, Silvana Gama Florencio, de Souza Paiva Ferreira, Adalgisa, de Macedo Bisio, Alessandra Porto, Brandão-Mello, Carlos Eduardo, Álvares-Da-Silva, Mário Reis, Reuter, Tânia, Ivantes, Claudia Alexandra Pontes, de Mello Perez, Renata, Mendes-Correa, Maria Cássia Jacintho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2017
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463255/
https://www.ncbi.nlm.nih.gov/pubmed/28658438
http://dx.doi.org/10.6061/clinics/2017(06)08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463255/
https://www.ncbi.nlm.nih.gov/pubmed/28658438
http://dx.doi.org/10.6061/clinics/2017(06)08

Ejemplares similares